Exchange: NASDAQ·Updated 07:30 PM EDT
ARVN logo

ARVN Arvinas Inc

$7.64
$0.13
(1.73%)
Today
Closed $7.64
$0.00
(0.00%)
After Hours
EarningsNov 4
Mkt Cap$499.55M
Vol560,048.00

About ARVN

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.
69

Bullish Sentiment

How do you feel about ARVN?

BluntForceOptions
$ARVN Finally pulled the trigger on this one with a 1/3 position. Watched it sit on the screen for months waiting for a decent entry, and this relentless sector fire sale gave me the opportunity to step in down here. The upside potential is way too big to ignore at these prices. If sellers want to keep pushing it lower, I’m happy to step in and build the rest.
5
BullDonald
$ARVN JESUS !! Brutal ! only good thin is the orderflow is green, indication a Acumulation from here
2
oaksapollo
$ARVN not too often you can buy a company of this quality, in a very compelling space (degraders) for less than cash on hand.
2
BullDonald
$ARVN I think i am the only one keeping the lights on, On this board LOL ARV-102 (LRRK2 Degrader): Arvinas is highlighting this neurodegenerative program as a top internal priority. The company plans to present additional biomarker data from its Phase 1 trial in Parkinson's disease patients at the International Congress on Parkinson's Disease and Movement Disorders in October 2026.đź’Ą They are also planning to initiate a Phase 1b trial for progressive supranuclear palsy (PSP).
2
BullDonald
$ARVN > So company Bought back shares worth ~90Mill arround ~9 !! > trading almost at cash in hand. > good cash runway and a Oncology pipeline. hmmm... this stock has all the potential to EXPLODE when time is right.
1

Advertisement|Remove ads.